- Published at
- by investing.com
positive
positive
Oxford BioDynamics seeks £500,000 via retail share offer By Investing.com
Oxford BioDynamics seeks £500,000 via retail share offer
News for Oxford BioDynamics Plc (OBD.L)
- Published at
- by investing.com
positivepositiveOxford BioDynamics issues shares to directors and staff By Investing.com
Oxford BioDynamics issues shares to directors and staff- Published at
- by investing.com
positivepositiveOxford BioDynamics explores funding amid share fluctuation By Investing.com
Oxford BioDynamics explores funding amid share fluctuation- Published at
- by investing.com
neutralneutralOxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy By Investing.com
Oxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy- Published at
- by marketscreener.com
positivepositiveOxford BioDynamics revenue up 49% in first half as test sales rise
Oxford BioDynamics PLC on Tuesday reported strong revenue growth on the back of the increased commercialisation of its EpiSwitch genomics platform. The Oxford, England-based biotechnology company has...- Published at
- by marketscreener.com
negativenegativeOxford BioDynamics develops canine cancer test with 89% accuracy
Oxford BioDynamics PLC on Tuesday announced the development of a canine cancer diagnostic test based on its EpiSwitch non-invasive platform. The Oxford, England-based biotechnology company said the...- Published at
- by marketscreener.com
mixedmixedBens Creek considers administration; Nexxen inks deal
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- Bens Creek Group PLC - owner and operator of...- Published at
- by marketscreener.com
mixedmixedAIM WINNERS & LOSERS: James Cropper falls on lower outlook -January 17, 2024 at 05:26 am EST
The following stocks are the leading risers and fallers on AIM in London on Wednesday. ---------- AIM - WINNERS ---------- Frontier Developments PLC, up 17% at 138.24 pence, 12-month range...- Published at
- by marketscreener.com
positivepositiveNet Asset Value(s)
Net Asset Value Seneca Growth Capital VCT Plc 12 October 2023 Net Asset Value Update for the period ended 30 September 2023 The Directors and the Investment Manager of the Company, Seneca...- Published at
- by globenewswire.com
positivepositiveNet Asset Value(s)
Net Asset Value(s) Seneca Growth Capital VCT Plc (the “Company”) 12 October 2023 Net Asset Value (“NAV”) Update for the period ended 30 September 2023 ...- Published at
- by marketscreener.com
positivepositiveKnights Group buys St James Law and Baines Wilson
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- SDX Energy PLC - London-based oil and gas company which... | May 2, 2023- Published at
- by globenewswire.com
positivepositiveMicroarray Analysis Market Set to Surge Past US$ 9.26 Billion by 2030 – Growth Plus Reports
Newark, New Castle, USA, March 29, 2023 (GLOBE NEWSWIRE) -- According to the latest analysis by Growth Plus Reports, the global microarray analysis...- Published at
- by marketscreener.com
mixedmixedB Share Portfolio Update
£0.2m follow-on investment made in August 2022 following our initial £0.4m investment at IPO. Arecor is developing a portfolio of proprietary products in diabetes and other indications... | December 21, 2022- Published at
- by globenewswire.com
mixedmixedB Share Portfolio Update
B Share Portfolio Update Seneca Growth Capital VCT Plc (the "Company") 21 December 2022 B Share Pool Investment Activity since 30 June 2022 Since the...- Published at
- by marketscreener.com
mixedmixedTRADING UPDATES: Uniphar takeover fails; Pearson notes redemption end
The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: ---------- Pearson PLC - London-based education publisher - Notes that... | December 16, 2022- Published at
- by prnewswire.com
mixedmixedCOVID-19 Nucleic Acid Amplification Tests (NAATs) Medical Devices Pipeline Market Report 2021: Analysis by Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Clinical Trials
/PRNewswire/ -- The "COVID-19 Nucleic Acid Amplification Tests (NAATs) - Medical Devices Pipeline Product Landscape, 2021" report has been added to...